SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039358
Filing Date
2020-08-11
Accepted
2020-08-11 17:18:11
Documents
92
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-10q_20200630.htm 10-Q 4372335
2 EX-10.1 bbio-ex101_317.htm EX-10.1 1167594
3 EX-31.1 bbio-ex311_6.htm EX-31.1 22097
4 EX-31.2 bbio-ex312_9.htm EX-31.2 22142
5 EX-32.1 bbio-ex321_7.htm EX-32.1 11918
6 EX-32.2 bbio-ex322_8.htm EX-32.2 11586
  Complete submission text file 0001564590-20-039358.txt   19063763

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bbio-20200630.xml EX-101.INS 4881492
8 XBRL TAXONOMY EXTENSION SCHEMA bbio-20200630.xsd EX-101.SCH 100549
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bbio-20200630_cal.xml EX-101.CAL 77621
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bbio-20200630_def.xml EX-101.DEF 426493
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20200630_lab.xml EX-101.LAB 707655
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20200630_pre.xml EX-101.PRE 626669
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 201093371
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences